55 related articles for article (PubMed ID: 16222053)
1. Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization.
Livingstone DE; McInnes KJ; Walker BR; Andrew R
Obes Res; 2005 Sep; 13(9):1523-6. PubMed ID: 16222053
[TBL] [Abstract][Full Text] [Related]
2. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats.
Barat P; Livingstone DE; Elferink CM; McDonnell CR; Walker BR; Andrew R
Endocrinology; 2007 Oct; 148(10):4836-43. PubMed ID: 17628001
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
Livingstone DE; Kenyon CJ; Walker BR
J Endocrinol; 2000 Dec; 167(3):533-9. PubMed ID: 11115781
[TBL] [Abstract][Full Text] [Related]
4. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.
Livingstone DE; Jones GC; Smith K; Jamieson PM; Andrew R; Kenyon CJ; Walker BR
Endocrinology; 2000 Feb; 141(2):560-3. PubMed ID: 10650936
[TBL] [Abstract][Full Text] [Related]
5. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.
Drake AJ; Livingstone DE; Andrew R; Seckl JR; Morton NM; Walker BR
Endocrinology; 2005 Feb; 146(2):913-9. PubMed ID: 15550507
[TBL] [Abstract][Full Text] [Related]
6. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
8. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
9. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
10. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
Jacobson PB; von Geldern TW; Ohman L; Osterland M; Wang J; Zinker B; Wilcox D; Nguyen PT; Mika A; Fung S; Fey T; Goos-Nilsson A; Grynfarb M; Barkhem T; Marsh K; Beno DW; Nga-Nguyen B; Kym PR; Link JT; Tu N; Edgerton DS; Cherrington A; Efendic S; Lane BC; Opgenorth TJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):191-200. PubMed ID: 15784656
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
12. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
14. Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.
Lessard SJ; Chen ZP; Watt MJ; Hashem M; Reid JJ; Febbraio MA; Kemp BE; Hawley JA
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E251-7. PubMed ID: 16118254
[TBL] [Abstract][Full Text] [Related]
15. Hepatic-dependent and -independent insulin actions are impaired in the obese Zucker rat model.
Afonso RA; Ribeiro RT; Fernandes AB; Patarrão RS; Macedo MP
Obesity (Silver Spring); 2007 Feb; 15(2):314-21. PubMed ID: 17299103
[TBL] [Abstract][Full Text] [Related]
16. Increase of anti-oxidation by exercise in the liver of obese Zucker rats.
Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT
Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):506-11. PubMed ID: 15298542
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
[TBL] [Abstract][Full Text] [Related]
18. Effects of phenobarbital on hepatic glucose metabolism and NADPH production in Zucker rats.
Karvonen I; Huupponen R; Niemelä KM; Sotaniemi E
Arch Int Pharmacodyn Ther; 1989; 302():40-8. PubMed ID: 2700066
[TBL] [Abstract][Full Text] [Related]
19. Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss.
Tomlinson JW; Finney J; Hughes BA; Hughes SV; Stewart PM
Diabetes; 2008 Jun; 57(6):1536-43. PubMed ID: 18340018
[TBL] [Abstract][Full Text] [Related]
20. Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion.
Sparks JD; Sparks CE
Biochem Biophys Res Commun; 1994 Nov; 205(1):417-22. PubMed ID: 7999057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
